Analyst Predicts $20bn COVID Vaccines Market In 2021

Pfizer Expected To Take Early Lead

Analysts have taken a first stab at predicting the size of the COVID-19 vaccine market – in which Pfizer and Moderna are likely to start strong, but could give way to other big players.

COVID-19 vaccine ampules

As the frontrunners in the race to develop a COVID-19 vaccine begin late-stage trials and sign multi-billion dollar deals to supply the US, European and Japan markets, the commercial picture for this new market is becoming clearer.

Pfizer Inc./BioNTech, Moderna, Inc. and AstraZeneca/Oxford all look capable of gaining an accelerated approval or emergency use authorization...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip